Decisions under risk in Parkinson's disease: Preserved evaluation of probability and magnitude

Neuropsychologia

Volumn 51, Issue 13, 2013, Pages 2679-2689

  Sharp, Madeleine E ^a   Viswanathan, Jayalakshmi ^a   McKeown, Martin J ^a   Appel Cresswell, Silke ^a   Stoessl, A Jon ^a   Barton, Jason J S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Decision making; Impulse control disorders; Parkinson's disease; Prospect theory

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION MAKING; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; GAMBLING; HUMAN; MALE; MENTAL TASK; OUTCOME ASSESSMENT; PARKINSON DISEASE; PERCEPTION DISORDER; PROBABILITY; PSYCHOMETRY; RISK ASSESSMENT; THEORETICAL MODEL;

DECISION-MAKING; IMPULSE CONTROL DISORDERS; PARKINSON'S DISEASE; PROSPECT THEORY;

AGED; ANTIPARKINSON AGENTS; CASE-CONTROL STUDIES; DECISION MAKING; FEMALE; GAMES, EXPERIMENTAL; HUMANS; IMPULSE CONTROL DISORDERS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PROBABILITY; PSYCHOMETRICS; RISK-TAKING;

EID: 84886233306     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2013.08.008     Document Type: Article

References (78)

1. Albanese A., Bonuccelli U., Brefel C., Chaudhuri K.R., Colosimo C., Eichhorn T., et al. Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Movement Disorders 2001, 16(2):197-201.
2. Antonelli F., Ray N., Strafella A.P. Imaging cognitive and behavioral symptoms in Parkinson's disease. Expert Review of Neurotherapeutics 2010, 10(12):1827-1838. 10.1586/ern.10.173.
3. Armitage P. Statistical methods in medical research 1980, Blackwell Scientific Publications, Oxford.
4. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4(6):561. 10.1001/archpsyc.1961.01710120031004.
5. Bodi N., Keri S., Nagy H., Moustafa A., Myers C., Daw N. Reward-learning and the novelty-seeking personality: A between-and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 2009.
6. Brand M., Kalbe E., Labudda K., Fujiwara E., Kessler J., Markowitsch H.J. Decision-making impairments in patients with pathological gambling. Psychiatry Research 2005, 133(1):91-99. (doi: S0165-1781(04)00253-7 [pii]). 10.1016/j.psychres.2004.10.003.
7. Brand M., Labudda K., Kalbe E., Hilker R., Emmans D., Fuchs G., et al. Decision-making impairments in patients with Parkinson's disease. Behavioral Neurology 2004, 15(3-4):77-85.
8. Breiter H.C., Aharon I., Kahneman D., Dale A., Shizgal P. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 2001, 30(2):619-639.
9. Christopoulos G.I., Tobler P.N., Bossaerts P., Dolan R.J., Schultz W. Neural correlates of value, risk, and risk aversion contributing to decision making under risk. The Journal of Neuroscience 2009, 29(40):12574-12583. 10.1523/JNEUROSCI.2614-09.2009.
10. Cloninger C.R., Svrakic D.M., Przybeck T.R. A psychobiological model of temperament and character. [Review]. Archives of General Psychiatry 1993, 50(12):975-990.
11. Cools R., Altamirano L., D'Esposito M. Reversal learning in Parkinson's disease depends on medication status and outcome valence. [Comparative Study]. Neuropsychologia 2006, 44(10):1663-1673. 10.1016/j.neuropsychologia.2006.03.030.
12. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. [Clinical Trial]. Neuropsychologia 2003, 41(11):1431-1441.
13. Cools R., Lewis S.J.G., Clark L., Barker R.A., Robbins T.W. l-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. [Clinical Trial]. Neuropsychopharmacology 2007, 32(1):180-189. 10.1038/sj.npp.1301153.
14. Czernecki V., Pillon B., Houeto J.L., Pochon J.B., Levy R., Dubois B. Motivation, reward, and Parkinson's disease: Influence of dopatherapy. Neuropsychologia 2002, 40(13):2257-2267.
15. Dagher A., Robbins T.W. Personality, addiction, dopamine: Insights from Parkinson's disease. [Review]. Neuron 2009, 61(4):502-510. 10.1016/j.neuron.2009.01.031.
16. Deakin J., Aitken M., Robbins T., Sahakian B.J. Risk taking during decision-making in normal volunteers changes with age. [Comparative Study]. Journal of the International Neuropsychological Society 2004, 10(4):590-598. 10.1017/S1355617704104104.
17. Dodd M.L., Klos K.J., Bower J.H., Geda Y.E., Josephs K.A., Ahlskog J.E. Pathological gambling caused by drugs used to treat Parkinson disease. [Comparative Study]. Archives of Neurology 2005, 62(9):1377-1381. 10.1001/archneur.62.9.noc50009.
18. Euteneuer F., Schaefer F., Stuermer R., Boucsein W., Timmermann L., Barbe M.T., et al. Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: A neuropsychological and psychophysiological study. [Controlled Clinical Trial]. Neuropsychologia 2009, 47(13):2882-2890. 10.1016/j.neuropsychologia.2009.06.014.
19. Fahn S., Elton R., Committee M.o.t.U.D Unified Parkinson's disease rating scale 1987, vol. 2:153-163. Recent developments in Parkinson's disease, Plutman Park, N.J.
20. Fellows L.K. Current concepts in decision-making research from bench to bedside. Journal of the International Neuropsychological Society : JINS 2012, 18(6):937-941. 10.1017/S1355617712001294.
21. Fiorillo C.D., Tobler P.N., Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science 2003, 299(5614):1898-1902. 10.1126/science.1077349.
22. Fox C., Poldrack R. Prospect theory and the brain. Neuroeconomics. Decision Making and the Brain 2009, 145-173.
23. Frank M., Samanta J., Moustafa A., Sherman S. Hold your horses: Impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007, 318(5854):1309.
24. Frank M., Seeberger L.C., O'reilly R.C. By carrot or by stick: Cognitive reinforcement learning in parkinsonism. Science 2004, 306(5703):1940-1943. 10.1126/science.1102941.
25. Glimcher P.W. Understanding risk: A guide for the perplexed. Cognitive, Affective, & Behavioral Neuroscience 2008, 8(4):348-354. 10.3758/CABN.8.4.348.
26. Grosset K., Needleman F., Macphee G., Grosset D. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five-drug dose conversion table. Movement Disorders: Official Journal of the Movement Disorder Society 2004, 19(11):1370-1374. 10.1002/mds.20210.
27. Harris C.R., Jenkins M., Glaser D. Gender differences in risk assessment: Why do women take fewer risks than men. Judgment and Decision Making 2006, 1(1):48-63.
28. Hoehn M. Parkinsonism. Neurology 1967, 17(5):427-442.
29. Hsu M., Bhatt M., Adolphs R., Tranel D., Camerer C.F. Neural systems responding to degrees of uncertainty in human decision-making. [Comment]. Science (New York, NY) 2005, 310(5754):1680-1683. 10.1126/science.1115327.
30. Hsu M., Krajbich I., Zhao C., Camerer C. Neural response to reward anticipation under risk is nonlinear in probabilities. Journal of Neuroscience 2009, 29(7):2231.
31. Hsu M., Krajbich I., Zhao C., Camerer C.F. Neural response to reward anticipation under risk is nonlinear in probabilities. Journal of Neuroscience 2009, 29(7):2231-2237. (doi: 29/7/2231 [pii]). 10.1523/JNEUROSCI.5296-08.2009.
32. Huettel S.A. Behavioral, but not reward, risk modulates activation of prefrontal, parietal, and insular cortices. Cognitive, Affective, & Behavioral Neuroscience 2006, 6(2):141-151.
33. Huettel S.A., Song A.W., McCarthy G. Decisions under uncertainty: Probabilistic context influences activation of prefrontal and parietal cortices. [Comparative Study]. Journal of Neuroscience 2005, 25(13):3304-3311. 10.1523/JNEUROSCI.5070-04.2005.
34. Huettel S.A., Stowe C.J., Gordon E.M., Warner B.T., Platt M.L. Neural signatures of economic preferences for risk and ambiguity. [Comparative Study]. Neuron 2006, 49(5):765-775. 10.1016/j.neuron.2006.01.024.
35. Kaasinen V., Någren K., Hietala J., Oikonen V., Vilkman H., Farde L., et al. Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease. [Clinical Trial]. Neurology 2000, 54(7):1482-1487.
36. Kahneman D. The framing of decisions and the psychology of choice. Science 1981.
37. Kapogiannis D., Mooshagian E., Campion P., Grafman J., Zimmermann T.J., Ladt K.C., et al. Reward processing abnormalities in Parkinson's disease. Movement Disorders 2011, 26(8):1451-1457. 10.1002/mds.23701.
38. Knutson B., Taylor J., Kaufman M., Peterson R., Glover G. Distributed neural representation of expected value. [Comparative Study]. Journal of Neuroscience 2005, 25(19):4806-4812. 10.1523/JNEUROSCI.0642-05.2005.
39. Kobayakawa M., Koyama S., Mimura M., Kawamura M. Decision making in Parkinson's disease: Analysis of behavioral and physiological patterns in the Iowa gambling task. Movement Disorders 2008, 23(4):547-552. 10.1002/mds.21865.
40. Lesieur H., Blume S. The South Oaks Gambling Screen (SOGS): A new instrument for the identification of pathological gamblers. American Journal of Psychiatry 1987, 144(9):1184.
41. Levy I., Snell J., Nelson A.J., Rustichini A., Glimcher P.W. Neural representation of subjective value under risk and ambiguity. Journal of Neurophysiology 2010, 103(2):1036-1047. 10.1152/jn.00853.2009.
42. Markowitz H. Portfolio Selection. The Journal of Finance 1952, 7(1):77-91. 10.1111/j.1540-6261.1952.tb01525.x.
43. Menza M., Golbe L., Cody R. Dopamine-related personality traits in Parkinson's disease. Neurology 1993, 43:505-508.
44. Moustafa A.A., Cohen M.X., Sherman S.J., Frank M.J. A role for dopamine in temporal decision making and reward maximization in parkinsonism. [Clinical Trial]. The Journal of Neuroscience 2008, 28(47):12294-12304. 10.1523/JNEUROSCI.3116-08.2008.
45. Nasreddine Z.S., Phillips N.A., Bédirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. [Evaluation Study]. Journal of the American Geriatrics Society 2005, 53(4):695-699. 10.1111/j.1532-5415.2005.53221.x.
46. Pagonabarraga J., García-Sánchez C., Llebaria G., Pascual-Sedano B., Gironell A., Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Movement Disorders 2007, 22(10):1430-1435. 10.1002/mds.21457.
47. Perretta J.G., Pari G., Beninger R.J. Effects of Parkinson disease on two putative nondeclarative learning tasks: Probabilistic classification and gambling. [Clinical Trial]. Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology 2005, 18(4):185-192.
48. Pessiglione M., Seymour B., Flandin G., Dolan R.J., Frith C.D. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. [Controlled Clinical Trial]. Nature 2006, 442(7106):1042-1045. 10.1038/nature05051.
49. Pine A., Seymour B., Roiser J.P., Bossaerts P., Friston K.J., Curran H.V., et al. Encoding of marginal utility across time in the human brain. Journal of Neuroscience 2009, 29(30):9575-9581. 10.1523/JNEUROSCI.1126-09.2009.
50. Pine A., Shiner T., Seymour B., Dolan R.J. Dopamine, time, and impulsivity in humans. [Research Support, Non-U.S. Gov't]. Journal of Neuroscience 2010, 30(26):8888-8896. 10.1523/JNEUROSCI.6028-09.2010.
51. Platt M.L., Glimcher P.W. Neural correlates of decision variables in parietal cortex. Nature 1999, 400(6741):233-238. 10.1038/22268.
52. Platt M.L., Huettel S.A. Risky business: The neuroeconomics of decision making under uncertainty. [Review]. Nature Neuroscience 2008, 11(4):398-403. 10.1038/nn2062.
53. Poletti M., Bonuccelli U. Personality traits in patients with Parkinson's disease: Assessment and clinical implications. [Review]. Journal of Neurology 2012, 259(6):1029-1038. 10.1007/s00415-011-6302-8.
54. Poletti M., Cavedini P., Bonuccelli U. Iowa gambling task in Parkinson's disease. Journal of Clinical and Experimental Neuropsychology 2011, 33(4):395-409. 10.1080/13803395.2010.524150.
55. Politis M., Loane C., Wu K., O'Sullivan S.S., Woodhead Z., Kiferle L., et al. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease. Brain 2013, 136(Pt 2):400-411. 10.1093/brain/aws326.
56. Rossi M., Gerschcovich E.R., Gerschcovich E.R., de Achaval D., Perez-Lloret S., Cerquetti D., et al. Decision-making in Parkinson's disease patients with and without pathological gambling. European Journal of Neurology 2010, 17(1):97-102. 10.1111/j.1468-1331.2009.02792.x.
57. Rutledge R.B., Lazzaro S.C., Lau B., Myers C., Gluck M.A., Glimcher P.W. Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task. [Clinical Trial]. The Journal of Neuroscience 2009, 29(48):15104-15114. 10.1523/JNEUROSCI.3524-09.2009.
58. Schonberg T., Fox C.R., Poldrack R.A. Mind the gap: Bridging economic and naturalistic risk-taking with cognitive neuroscience. Trends in Cognitive Sciences 2011, 15(1):11-19. 10.1016/j.tics.2010.10.002.
59. Schonberg T., O'Doherty J.P., Joel D., Inzelberg R., Segev Y., Daw N.D. Selective impairment of prediction error signaling in human dorsolateral but not ventral striatum in Parkinson's disease patients: Evidence from a model-based fMRI study. NeuroImage 2010, 49(1):772-781. 10.1016/j.neuroimage.2009.08.011.
60. Schultz W. The reward signal of midbrain dopamine neurons. News in Physiological Sciences 1999, 14:249-255.
61. Schultz W. Behavioral theories and the neurophysiology of reward. [Review]. Annual Review of Psychology 2006, 57:87-115. 10.1146/annurev.psych.56.091103.070229.
62. Sharp M.E., Viswanathan J., Lanyon L.J., Barton J.J.S. Sensitivity and bias in decision-making: Evaluating the perception of reward, its probability, and value. PLoS One 2012, 7(e33460):1-9.
63. Shohamy D., Foerde K. The role of the basal ganglia in learning and memory: Insight from Parkinson's disease. Neurobiology of Learning and Memory 2011, 10.1016/j.nlm.2011.08.006.
64. Simpson T. Vision thresholds from psychometric analyses: Alternatives to probit analysis. Optometry and Vision Science 1995, 72:371-377.
65. Sugrue L.P., Corrado G.S., Newsome W.T. Matching behavior and the representation of value in the parietal cortex. Science 2004, 304(5678):1782-1787. 10.1126/science.1094765.
66. Tobler P.N., O'Doherty J.P., Dolan R.J., Schultz W. Reward value coding distinct from risk attitude-related uncertainty coding in human reward systems. [Clinical Trial]. Journal of Neurophysiology 2007, 97(2):1621-1632. 10.1152/jn.00745.2006.
67. Toplak M.E., Sorge G.B., Benoit A., West R.F., Stanovich K.E. Decision-making and cognitive abilities: A review of associations between Iowa Gambling Task performance, executive functions, and intelligence. [Review]. Clinical Psychology Review 2010, 30(5):562-581. 10.1016/j.cpr.2010.04.002.
68. Torta D.M.E., Castelli L., Zibetti M., Lopiano L., Geminiani G. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: Does the therapy-dose matter?. Brain and Cognition 2009, 71(2):84-91. 10.1016/j.bandc.2009.04.003.
69. Trepel C., Fox C.R., Poldrack R.A. Prospect theory on the brain? Toward a cognitive neuroscience of decision under risk. [Review]. Cognitive Brain Research 2005, 23(1):34-50. 10.1016/j.cogbrainres.2005.01.016.
70. van Eimeren T., Ballanger B., Pellecchia G., Miyasaki J.M., Lang A.E., Strafella A.P. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: A trigger for pathological gambling in Parkinson's disease? [Clinical Trial]. Neuropsychopharmacology 2009, 34(13):2758-2766. 10.1038/sj.npp.npp2009124.
71. Voon V., Gao J., Brezing C., Symmonds M., Ekanayake V., Fernandez H., et al. Dopamine agonists and risk: Impulse control disorders in Parkinson's disease. [Clinical Trial]. Brain 2011, 134(Pt 5):1438-1446. 10.1093/brain/awr080.
72. Voon V., Hassan K., Zurowski M., de Souza M., Thomsen T., Fox S., et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006, 67(7):1254-1257. 10.1212/01.wnl.0000238503.20816.13.
73. Voon V., Pessiglione M., Brezing C., Gallea C., Fernandez H.H., Dolan R.J., et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010, 65(1):135-142. 10.1016/j.neuron.2009.12.027.
74. Voon V., Reynolds B., Brezing C., Gallea C., Skaljic M., Ekanayake V., et al. Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology 2010, 207(4):645-659. 10.1007/s00213-009-1697-y.
75. Weintraub D. Dopamine and impulse control disorders in Parkinson's disease. Annals of Neurology 2008, 64(Suppl. 2):S93-S100. 10.1002/ana.21454.
76. Weintraub D., Hoops S., Shea J.A., Lyons K.E., Pahwa R., Driver-Dunckley E.D., et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Movement Disorders 2009, 24(10):1461-1467. 10.1002/mds.22571.
77. Weintraub D., Koester J., Potenza M., Siderowf A., Stacy M., Voon V., et al. Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Archives of Neurology 2010, 67(5):589. 10.1001/archneurol.2010.65.
78. Yacubian J., Gläscher J., Schroeder K., Sommer T., Braus D.F., Büchel C. Dissociable systems for gain- and loss-related value predictions and errors of prediction in the human brain. Journal of Neuroscience 2006, 26(37):9530-9537. 10.1523/JNEUROSCI.2915-06.2006.